NetworkNewsBreaks – Lexaria Bioscience Corp. (CS
Post# of 721
(Total Views: 176)
Posted On: 06/24/2019 3:32:29 PM
NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Releases 2019 Annual and Special Meeting Results
Biotechnology company and drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) on Friday announced the results of its 2019 annual and special meeting. Held on June 20, 2019, there were 43,217,711 company shares represented in person or by proxy at the meeting, constituting 55.1 percent of Lexaria’s issued share capital as of May 3, 2019, the record date of the meeting. The matters voted upon included board member elections, the appointment of Davidson & Company LLP as auditors, approval of the company’s equity incentive plan and executive compensation, and the timeline for approval of executive compensation going forward.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Biotechnology company and drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) on Friday announced the results of its 2019 annual and special meeting. Held on June 20, 2019, there were 43,217,711 company shares represented in person or by proxy at the meeting, constituting 55.1 percent of Lexaria’s issued share capital as of May 3, 2019, the record date of the meeting. The matters voted upon included board member elections, the appointment of Davidson & Company LLP as auditors, approval of the company’s equity incentive plan and executive compensation, and the timeline for approval of executive compensation going forward.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Lexaria Bioscience Corp. (LXRPD) Stock Research Links
Scroll down for more posts ▼